Potential Arrhythmogenic Risk of DDI/DDD Pacing Modes During Atrial Fibrillation
Journal Title: Journal of Cardiovascular Medicine and Cardiology - Year 2014, Vol 1, Issue 2
Abstract
In patients with paroxysmal-persistent atrial fibrillation (AF), DDI and DDD pacing modes can be used to assess the clinical burden of AF. This report shows how the DDI mode might trigger ventricular tachyarrhythmias during AF. This potential arrhythmogenic phenomenon should be carefully considered when programming a device in DDI (or DDD) mode in patients with AF.
Authors and Affiliations
Giacomo Mugnai, Livio Bertagnolli, Ruggero Tomei
Hydrogels for Cardiac Tissue Repair and Regeneration
The main cause of death in the world continues to be cardiovascular disease, which affects annually over 900,000 people and in the entire word approximately 50% of the people suffering myocardial infarction (MI) die with...
Cardiac Myxomas - Symptomology, Investigations and Surgical Treatment - Single Centre Experience of Fifteen Years at Grant Medical College, Mumbai, Maharashtra
Introduction: The aim of study is to describe the clinical symptoms, investigation findings and surgical treatment of cardiac myxomas. Method: From May 2002 to May 2017, 50 patients of primary or recurrent intracardiac m...
Complete Left Pericardial Agenesis associated with Ventricular Septal Defect
9 years old male patient admitted to our department with complaints of recurrent respiratory tract infection since 2 years of age. No History of cyanosis His left eye is absent and it was the abnormality at birth.
Efficacy and Safety of Different Energy Settings for Atrial Fibrillation Ablation using the Duty-cycled Radiofrequency Ablation Catheter (PVAC)
In recent years, new ablation catheters have been developed to facilitate atrial fibrillation (AF) ablation procedures, including the multi-electrode pulmonary vein ablation catheter (PVAC), capable of using different pr...
Can Irisin be a New Agent Responsible for the Development of Heart Attack and Cardiac Cachexia?
Cardiac cachexia, a syndrome characterized by systemic destruction, nutritional impairment and weight loss [1], has a prevalence ranging between 8 and 42% around the world [2]. The syndrome was first described by the fat...